Pages that link to "Q34418506"

The following pages link to Psoriasis and comorbidities: links and risks (Q34418506):

Displaying 25 items.

• Environmental Risk Factors in Psoriasis: The Point of View of the Nutritionist (Q26741784) (← links)
• Psoriasis, non-alcoholic fatty liver disease, and cardiovascular disease: Three different diseases on a unique background (Q26765175) (← links)
• Psoriasis and Metabolic Syndrome--scientific evidence and therapeutic implications (Q35045850) (← links)
• Nutrition and psoriasis: is there any association between the severity of the disease and adherence to the Mediterranean diet? (Q35047630) (← links)
• Non-alcoholic fatty liver disease and psoriasis: So far, so near (Q35237307) (← links)
• Genome-wide Association Analysis of Psoriatic Arthritis and Cutaneous Psoriasis Reveals Differences in Their Genetic Architecture (Q36369917) (← links)
• Presence of selected metabolic syndrome components in patients with psoriasis vulgaris (Q36946167) (← links)
• Profile of patients admitted to a triage dermatology clinic at a tertiary hospital in São Paulo, Brazil (Q37078902) (← links)
• An evolution in switching therapy for psoriasis patients who fail to meet treatment goals (Q37295966) (← links)
• Role of IL-17 in plaque psoriasis: therapeutic potential of ixekizumab (Q37712237) (← links)
• Association of obesity with patient-reported outcomes in patients with axial spondyloarthritis: a cross-sectional study in an urban Asian population (Q38854206) (← links)
• Stress-related skin disorders (Q38883601) (← links)
• Prevalence of Metabolic Syndrome in Psoriasis and Levels of Interleukin-6 and Tumor Necrosis Factor-α in Psoriasis Patients with Metabolic Syndrome: Indian Tertiary Care Hospital Study (Q41515491) (← links)
• Psoriasis and Cardiovascular Risk-Do Promising New Biomarkers Have Clinical Impact? (Q41693144) (← links)
• Moderate to severe psoriasis treatment challenges through the era of biological drugs (Q46452013) (← links)
• Subjective Health Complaints in Individuals with Psoriasis and Psoriatic Arthritis: Associations with the Severity of the Skin Condition and Illness Perceptions - A Cross-Sectional Study (Q47347206) (← links)
• The impact of biologic agents on health-related quality of life outcomes in patients with psoriasis (Q47644680) (← links)
• The Potential Role of Inhibitory Receptors in the Treatment of Psoriasis (Q50119256) (← links)
• Prevalence and Possible Role of Candida Species in Patients with Psoriasis: A Systematic Review and Meta-Analysis. (Q55041240) (← links)
• Young patients with risk factors prevalent in the elderly – differences in comorbidity depending on severity of psoriasis: a nationwide cross-sectional study in Swedish health registers. (Q55312824) (← links)
• Level of inflammatory cytokines tumour necrosis factor α, interleukins 12, 23 and 17 in patients with psoriasis in the context of metabolic syndrome (Q64250717) (← links)
• Assessment of subclinical cardiac damage in chronic plaque psoriasis patients: a case control study (Q88979554) (← links)
• Hypovitaminosis D is Associated with Psoriasis: A Systematic Review and Meta-Analysis (Q91709169) (← links)
• Risk of non-melanoma skin cancer in patients with psoriasis: An updated evidence from systematic review with meta-analysis (Q92758002) (← links)
• Diterpenoids and Triterpenoids From Frankincense Are Excellent Anti-psoriatic Agents: An in silico Approach (Q97526290) (← links)